Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Roche scientists (Nutley, N.J.) and collaborators published animal data showing that IL-12 blocks angiogenesis of corneal blood vessels. This
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury